#commnexus

Genetic_DNA_Reports_Pathway_Genomics.mp4 Watch on Posterous

Michael Nova, M.D., Pathway Genomics’ chief medical officer, is scheduled to participate in a panel discussion focusing on the convergence of genomic and digital technology, and the impact it will have – and is having – on the ways in which health care is delivered. Sponsored by CommNexus, a forward-thinking non-profit technology industry association, the event will center on MD Revolution, a San Diego-based medical practice that currently uses genomic and digital technology to shift the medical paradigm from delivering reactive disease care to empowering proactive health care.

“We are on the cusp of a major revolution in traditional medicine – one that will empower patients through vital and actionable genetic information,” said Dr. Nova.

“We are on the cusp of a major revolution in traditional medicine – one that will empower patients through vital and actionable genetic information,” said Dr. Nova. “Clinics like MD Revolution are at the very forefront of this movement and are leading the charge towards a more efficient and personalized health care experience.”

  Dr. Nova will primarily focus on the connections between nutrition, lifestyle and genetic expression – the impetus behind Pathway Fit®, the company’s nutrigenetic test. Pathway Fit has been used by thousands of patients for a wide variety of reasons, including weight management, diabetes control, general metabolism function, and eating behavioral insights.